Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
BMC Dermatology|December 20, 2020
Effects of variations in access to care for children with atopic dermatitisElaine C Siegfried, Amy S Paller, Paola Mina-Osorio, et al.Journal of the Endocrine Society|May 9, 2022
Natural History of Obesity Due to POMC, PCSK1, and LEPR Deficiency and the Impact of SetmelanotideMartin Wabitsch, Sadaf Farooqi, Christa E Flück, et al.Journal of the American Academy of Dermatology|August 11, 2019
Treatment patterns of pediatric patients with atopic dermatitis: A claims data analysisAmy S Paller, Elaine C Siegfried, Francis Vekeman, et al.American Heart Journal|December 11, 2017
Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP studyAlan S Go, Dongjie Fan, Sue Hee Sung, et al.Journal of the American Academy of Dermatology|November 10, 2021
Prevalence of type 2 inflammatory diseases in pediatric patients with atopic dermatitis: Real-world evidenceAmy S Paller, Paola Mina-Osorio, Francis Vekeman, et al.BMC Dermatology|November 7, 2019
Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitisEric Simpson, Laurent Eckert, Abhijit Gadkari, et al.Orphanet Journal of Rare Diseases|February 6, 2022
Quality of life outcomes in two phase 3 trials of setmelanotide in patients with obesity due to LEPR or POMC deficiencyPeter Kühnen, Martin Wabitsch, Julia von Schnurbein, et al.Current Medical Research and Opinion|November 29, 2019
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)David M Pariser, Eric L Simpson, Abhijit Gadkari, et al.Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.Orphanet Journal of Rare Diseases|January 16, 2023
Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial resultsElizabeth Forsythe, Robert M Haws, Jesús Argente, et al.Pageof 4